Doximity Inc (NYSE:DOCS) shares traded -10.08% lower at $52.56 on Wall Street last session.
DOCS stock price is now -9.32% away from the 50-day moving average and 1.93% away from the 200-day moving average. The market capitalization of the company currently stands at $9.86B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $31 to $78, Piper Sandler Upgraded its rating from Neutral to Overweight for Doximity Inc (NYSE: DOCS). On February 07, 2025, Leerink Partners Upgraded its previous ‘Market Perform’ rating to ‘Outperform’ on the stock increasing its target price from $60 to quote $90, while ‘Stephens’ rates the stock as ‘Equal-Weight’
In other news, Wampler Kira Scherer, Director sold 2,000 shares of the company’s stock on May 01 ’25. The stock was sold for $113,853 at an average price of $56.93. Upon completion of the transaction, the Director now directly owns 16,618 shares in the company, valued at $0.87 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 02 ’25, Chief Financial Officer Bryson Anna sold 50,000 shares of the business’s stock. A total of $3,000,000 was realized by selling the stock at an average price of $60.00. This leaves the insider owning 357,165 shares of the company worth $18.77 million. A total of 30.93% of the company’s stock is owned by insiders.
During the past 12 months, Doximity Inc has had a low of $23.52 and a high of $85.21. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 6.97, and a quick ratio of 8.67.
The net profit margin was 39.13% and return on equity was 22.50% for DOCS. The company reported revenue of $138.29 million for the quarter, compared to $118.06 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 17.14 percent.
